Pharmaceutical Company Chooses Optiv to Secure COVID-19 Vaccine Production

February 03, 2023

A global pharmaceutical manufacturer was tasked with mass producing a vaccine for COVID-19, but they needed to improve their operational security. Read the case study to learn how Optiv helped them maintain a high level of production quality and uptime while protecting their intellectual property.